Gordon Daniels is an innovative commercial strategist with a proven track record in managing nearly 30 medicines across seven therapeutic areas in 115 countries. He has successfully led seven product launches over the past decade, demonstrating his strategic focus on customer engagement.
With experience across North America and Europe, Gordon brings deep market insight and a proven ability to deliver impactful solutions. He began his career at Procter & Gamble in Canada, rising to Global Marketing Director for its flagship rheumatology brand in the US – establishing himself as a world-class marketer. He later held General Management roles in France and the UK.
At GlaxoSmithKline, Gordon led regional and global roles, including Executive Marketing Director for respiratory, where he developed a comprehensive COPD strategy and pioneered digital launch approaches. At Recordati Rare Diseases, he expanded the European commercial footprint, launched in rare diseases, and enhanced customer engagement through AI.
With over 25 years of experience spanning oncology, urology, metabolics, and more, Gordon is known for his agility and innovation. He is completing the Chief Marketing Officer program at Kellogg School of Management, reinforcing his expertise in commercial strategy and AI for business transformation.
